zidovudine has been researched along with u 75875 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borchardt, RT; Chong, KT; Fisher, JF; Hui, JO; Islam, I; McQuade, TJ; Ng, KY; Rush, BD; Ruwart, MJ; Wilkinson, KF | 1 |
| Aquaro, S; Bergamini, A; Capozzi, M; D'Agostini, C; Milanese, G; Perno, CF; Pesce, CD; Tarpley, WG; Thaisrivongs, S; Zon, G | 1 |
| Bergamini, A; Bolacchi, F; Bongiovanni, B; Capozzi, M; Cappelli, G; Cepparulo, M; Colizzi, V; Mancino, G; Rocchi, G; Uccella, I | 1 |
3 other study(ies) available for zidovudine and u 75875
| Article | Year |
|---|---|
Evaluation of a vitamin-cloaking strategy for oligopeptide therapeutics: biotinylated HIV-1 protease inhibitors.
Topics: Animals; Biological Availability; Biotin; Drug Synergism; HIV Protease Inhibitors; HIV-1; Humans; Male; Rats; Rats, Sprague-Dawley; Receptors, Growth Factor; Tumor Cells, Cultured | 1994 |
Inhibition of the protease of human immunodeficiency virus blocks replication and infectivity of the virus in chronically infected macrophages.
Topics: Antiviral Agents; Genes, rev; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Macrophages; Oligodeoxyribonucleotides; Oligonucleotides, Antisense; Oligopeptides; Thionucleotides; Transcription, Genetic; Virulence; Virus Replication; Zidovudine | 1993 |
Human immunodeficiency virus type 1 infection modulates the interleukin (IL)-1beta and IL-6 responses of human macrophages to CD40 ligand stimulation.
Topics: Anti-HIV Agents; Antibodies, Monoclonal; CD40 Ligand; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Interleukin-1; Interleukin-6; Macrophages; Oligopeptides; Polymerase Chain Reaction; RNA, Messenger; Virus Replication; Zidovudine | 2000 |